Press release
Global Nephritis Treatment Medicines Market Worth USD 3.35 Billion by 2025 | Key Players:Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc., AstraZeneca, and Eli Lilly.
Global Nephritis Treatment Medicines Market
In the year 2017, Global Nephritis Treatment Medicines Market was valued at USD 1.25 Billion. By the year 2025, it is expected to grow at a CAGR of 13.11% to reach USD 3.35 Billion.
Nephritis is an inflammation of the kidneys which is caused by systemic lupus erythematosus (SLE). Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs like kidneys, joints, skin, and brain. Nephritis disease has several causes which can lead to kidney failure if it’s left untreated. The primary cause of Nephritis disease is unknown, but it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history play a role in causing the disease. The main symptoms caused due to nephritis are the flank pain, dark urine, and weight gain due to retention of extra fluid, swelling of hands, feet, eyes, and high blood pressure. Medications used in the treatment of Nephritis disease include immunosuppressive drugs, corticosteroids, and other drugs to prevent blood clots and low blood pressure.
Browse details of research report developed on Global Nephritis Treatment Medicines Market @ https://www.researchcosmos.com/reports/global-nephritis-treatment-medicines-market-forecast-2017-2025-industry-analysis-report/6818807
Underlying Causes
The Global Nephritis Treatment Medicines Market is mainly driven due to the factors like increasing kidney infections across the globe, growing awareness about the nephritis treatment among the global population, rising R&D activities, introduction of new biologic drugs, and advancement of technologies in the medical industry. In addition, increasing healthcare expenditure, rising aging population, and improving healthcare facilities in developing countries are contributing to the high growth rate for Global Nephritis Treatment Medicines Market. However, stringent regulatory policies, a high cost of nephritis treatment and lack of skilled professionals in the developing countries are declining the market growth rate during the forecast period.
Avail Sample Market Brochure of the report for more information, Get a Copy @ https://www.researchcosmos.com/request/global-nephritis-treatment-medicines-market-forecast-2017/6818807
Geographic Segmentation:
Based on geography, the Nephritis Treatment Medicines Market has been primarily divided into Asia Pacific, Middle East and Africa, North America and Latin America. North America holds the largest market share in the Nephritis Treatment Medicines Market followed by Europe due to increasing kidney infections and other disorders, increasing healthcare expenditures, advancement of technologies, growing R&D activities, and rise in awareness about nephritis treatment in the region. The Asia-Pacific region is rapidly growing due to increase in healthcare expenditure, rising geriatric population, increasing disposable income, rising prevalence of kidney diseases, growing awareness about nephritis drugs, improving healthcare facilities and rising complications of kidney disorders in many rural areas, which can fuel the growth rate for Nephritis Treatment Medicines Market during the forecast period.
Inquire Before Buying@ https://www.researchcosmos.com/inquire/global-nephritis-treatment-medicines-market-forecast-2017/6818807
Key Players:
Leading companies for Global Nephritis Treatment Medicines Market are Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc., AstraZeneca, and Eli Lilly.
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
kevin@researchcosmos.com
+1 888 709 8757
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nephritis Treatment Medicines Market Worth USD 3.35 Billion by 2025 | Key Players:Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc., AstraZeneca, and Eli Lilly. here
News-ID: 1214336 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Nephritis
Lupus Nephritis Market Massive Growth opportunity Ahead
Introduction
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease in which the immune system attacks multiple organs. In LN, inflammation damages the kidneys' filtering units, leading to proteinuria, hypertension, and eventual renal failure if untreated. Up to 60% of lupus patients develop nephritis, making it one of the most serious complications of SLE.
For decades, treatment centered on corticosteroids and immunosuppressants such as cyclophosphamide, mycophenolate…
Lupus Nephritis Treatment Market Share Forecast till 2030
According to Ameco Research 'Lupus Nephritis Treatment Market report, the analysts took this into account when estimating the Lupus Nephritis Treatment Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Lupus Nephritis Treatment Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Lupus Nephritis Treatment…
Lupus Nephritis Treatment Market Industry Analysis Report 2022 - 2030
Lupus Nephritis, a complication of systemic lupus erythematosus (SLE), poses significant challenges to healthcare. The global market, valued at USD 4,392 million in 2021, is projected to reach USD 8,048 million by 2030. Innovations in treatment options and advancements in research are key drivers of this growth, despite challenges such as disease complexity and treatment side effects.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276700
Key Points and Statistics:
• Projected market…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Nephritis Market Trends and Growth Factors Analysis
Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history…
Lupus Nephritis Market - Worldwide Industry Volume And Region Analysis - 2023
Global Lupus Nephritis Market
Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along…
